Next, we computed the PCC between CBX2 and CEP55 to validate their positive regulatory relationship across cancers and confirmed that a significantly positive correlation greater than 0.2 was observed in 27/33 cancers, especially in THYM (Figure 7E, 7D). Here, CBX2 is linked to cancer.